Skip to content

Assessment of the Effect of Tumor Thickness and Site on Level IV Cervical Lymph Nodes in Squamous Cell Carcinoma of the Tongue and Floor of the Mouth: A Case Series Study

Assessment of the Effect of Tumor Thickness and Site on Level IV Cervical Lymph Nodes in Squamous Cell Carcinoma of the Tongue and Floor of the Mouth: A Case Series Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06169605
Enrollment
20
Registered
2023-12-13
Start date
2024-04-01
Completion date
2025-05-30
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tongue Neoplasms

Brief summary

Regarding oral cavity cancer, the high incidence of neck metastasis along with its impact on survival and prognosis are in favor of elective neck dissection. Moreover, occult metastases could develop at lower levels in the neck (levels IV-V) Regarding the tongue, the rate of skip (occult) metastasis involving unremoved level IV cervical lymph nodes in squamous cell carcinoma of the tongue ranges from 0 % - 11.4 %. However, no data is available or a correlation between the risk of level IV involvement and the affection of specific tongue subsites or a certain cutoff value of tumor thickness.

Interventions

PROCEDUREremoval of primary tumor, neck dissection

removal of the primary tumor with safety margins and removal of the neck lymph node levels I, II, III and IV. histological assessment of tumor thickness and whether it is associated with positive nodes in level IV or not.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with squamous cell carcinoma of the tongue and floor of the mouth. * Age group: from 15 to 60 years old * No sex predilection

Exclusion criteria

* Patients with recurrent squamous cell carcinoma of the tongue and floor of the mouth. * Irradiated patients or those taking chemotherapy.

Design outcomes

Primary

MeasureTime frameDescription
tumor thickness in mellimetersone week: specimens are submitted immediately after surgeryhistological assessment of tumor thickness of the resected tumor and assessment of level IV lymph nodes
Number of affected level IV cervical lymph nodesOne week : submitted immediately after surgeryIn each case the specimen will be assessed for level IV lymph nodes affection

Secondary

MeasureTime frameDescription
affected tongue site in relation to level IV cervical lymph nodesOne weekhistological assessment of level IV lymph nodes to determine if it is affected with tumor site on the tongue (lateral border, dorsum, ventral ....) which will be documented before surgery during examination

Countries

Egypt

Contacts

Primary ContactMohamed Shawky, MSc
m.shawky1993@gmail.com+201223933897

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026